-

TransPerfect Life Sciences Unveils AI-Powered TMF Automation with Trial Interactive 10.2

NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, today announced its release of version 10.2 of the award-winning Trial Interactive eClinical platform. The latest enhancements enable study teams to expedite TMF document processing and simplify oversight.

Trial Interactive delivers user-friendly document and trial management solutions to help pharmaceutical, biotechnology, and CRO companies effectively streamline product development lifecycles. The platform improves speed, quality, and compliance across site identification, site feasibility, study start-up, personnel training, regulated content management, eISF, eTMF management, and more. A fully connected solution, Trial Interactive offers fast-to-implement and cost-effective solutions in a secure 21 CFR Part 11 compliant environment.

The updated Trial Interactive 10.2 platform introduces these thematic improvements:

  • Enterprise eTMF: Time-saving, convenient, and simple TMF document processing that supports an enterprise author-to-archive approach with features like query management, planned documents, responsibilities, and due date reminders
  • TMF Automation: Strategically applied machine learning to improve quality and expedite document processing with metadata extraction, auto-classification, and scanning
  • TMF Best Practice: Enhanced oversight and compliance via portfolio dashboards with timeliness metrics, eTMF health KPIs, instant audit trials, and the capability to certify copies via mobile device
  • Events Management: Ability to manage amendments, milestones, visits, and other updates to the eTMF and apply events to eTMF required document and placeholder definitions

TransPerfect’s Trial Interactive has an extensive track record of ensuring global study teams operate efficiently through all phases of a clinical trial, facilitating inspection readiness and helping bring life-changing therapies to patients. The eClinical platform is built by clinical professionals for clinical professionals—with a practical approach to innovation and collaboration powered by industry experts.

Michael Smyth, Division President of TransPerfect Life Sciences Solutions, stated, “Trial Interactive 10.2 answers calls from study teams to use AI and machine learning to complete essential TMF processes automatically. We know the importance of quality, completeness, and timeliness and believe 10.2 helps fulfill our mission to provide clients with the tools to meet regulatory requirements and enhance clinical trial strategies.”

TransPerfect President and CEO Phil Shawe commented, “Introducing our first AI-powered TMF automation is a great step forward for Trial Interactive clients. The faster document processing is for study teams, the faster sponsors can bring treatments to patients.”

To schedule a demo of Trial Interactive, email info@trialinteractive.com.

About Trial Interactive

TransPerfect’s Trial Interactive is an industry leader in practical eClinical innovation that simplifies and automates clinical processes for sponsors, CROs, and sites around the world. The 21 CFR part 11 compliant unified platform delivers an author-to-archive collaboration experience with solutions for clinical document management, site selection, site activation, eLearning, compliance training, quality, and more with seamless solution interoperability and indexing to the eTMF. Trial Interactive is consistently selected by clinical professionals for providing the most comprehensive yet intuitive experience with the most complete offering of technology and expert TMF services. Trial Interactive helps study teams streamline their operations by cutting unnecessary expenses, expediting timelines, reducing compliance risks, and improving operational excellence. For more information on Trial Interactive, please contact info@trialinteractive.com or +1 212.400.8848, or visit www.trialinteractive.com.

About TransPerfect Life Sciences

TransPerfect Life Sciences specializes in supporting global development and commercialization of drugs, treatments, and devices designed to improve and save lives. Our comprehensive solutions include eTMF and eClinical technologies, paper TMF migration, pharmacovigilance and safety solutions, translation and language services, and call center support. With offices in over 100 cities worldwide, TransPerfect is the ideal partner to ensure that your global launch makes a global impact. For more information, please visit our website at www.lifesciences.transperfect.com.

Contacts

Ryan Simper +1 212.689.5555
mediainquiry@transperfect.com

TransPerfect Life Sciences

Details
Headquarters: New York, NY
CEO: Phil Shawe
Employees: 7,500
Organization: PRI
Revenues: $1.1 billion (2021)

Release Versions

Contacts

Ryan Simper +1 212.689.5555
mediainquiry@transperfect.com

More News From TransPerfect Life Sciences

TransPerfect Wins Two Entertainment Globalization Association (EGA) Hermes Awards

NEW YORK--(BUSINESS WIRE)--TransPerfect, the world's largest provider of language and technology solutions for global business, today announced that it has been honored as a winner and finalist for the Entertainment Globalization Association (EGA) Hermes Awards across multiple categories. TransPerfect Media, the division of TransPerfect that specializes in media globalization solutions to enable storytelling for international audiences, received awards for: Technical Achievement: StudioNEXT Lif...

Independent Research Report Determines Savings of $3.4 Million for a Top 10 US Bank with TransPerfect’s GlobalLink Technology

NEW YORK--(BUSINESS WIRE)--TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced the results of a recent Forrester report, “The Total Economic Impact™ of TransPerfect’s OneLink and AI Portal: Cost Savings and Business Benefits Enabled by OneLink and AI Portal for a Global Financial Institution,” which calculated a savings value of $3.4 million. Forrester conducted all research independently and maintained editorial control over all...

TransPerfect’s GlobalLink Adobe Experience Manager (AEM) Integration Streamlines Translation for 27 Global Brands in 2022

NEW YORK--(BUSINESS WIRE)--TransPerfect, the world’s largest provider of language and technology solutions for global business, today announced that in 2022, 27 leading global brands, including UPS, Nikon, Microsoft, Bridgestone, and Eaton, implemented the company’s GlobalLink Translation Management System (TMS) integrated with Adobe Experience Manager (AEM) to automate the creation and maintenance of their global enterprise content. The updated integration now allows customers to leverage Glob...
Back to Newsroom